Intelligent Bio Solutions Inc.
INBS
$1.70
-$0.06-3.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.95% | -11.52% | -20.49% | 9.57% | 64.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.95% | -11.52% | -20.49% | 9.57% | 64.25% |
| Cost of Revenue | 679.59% | -39.95% | -31.94% | -6.79% | -122.28% |
| Gross Profit | -58.85% | 91.26% | 12.00% | 49.29% | 1,544.35% |
| SG&A Expenses | 1.78% | -0.75% | 6.11% | -20.68% | 9.80% |
| Depreciation & Amortization | 5.55% | -5.30% | 5.13% | -2.34% | 67.75% |
| Other Operating Expenses | -392.81% | -106.80% | 12.79% | -14.74% | -99.74% |
| Total Operating Expenses | 5.25% | -13.11% | 4.23% | 8.28% | 14.79% |
| Operating Income | -2.49% | 13.56% | -13.71% | -7.87% | -6.49% |
| Income Before Tax | -10.99% | 14.60% | -14.19% | -10.79% | -4.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.99% | 14.60% | -14.19% | -10.79% | -4.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.61% | -21.98% | 8.96% | 27.78% | -11.20% |
| Net Income | -10.99% | 14.58% | -14.21% | -10.74% | -4.71% |
| EBIT | -2.49% | 13.56% | -13.71% | -7.87% | -6.49% |
| EBITDA | -2.08% | 13.80% | -14.63% | -8.99% | -2.20% |
| EPS Basic | 51.79% | 69.22% | 76.09% | 94.36% | 96.38% |
| Normalized Basic EPS | 55.23% | 69.21% | 76.08% | 94.36% | 96.30% |
| EPS Diluted | 51.87% | 69.22% | 76.09% | 94.36% | 96.38% |
| Normalized Diluted EPS | 55.23% | 69.21% | 76.08% | 94.36% | 96.30% |
| Average Basic Shares Outstanding | 130.18% | 177.51% | 377.60% | 1,862.46% | 2,795.90% |
| Average Diluted Shares Outstanding | 130.18% | 177.51% | 377.60% | 1,862.46% | 2,795.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |